The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years after being declared in shortage by the Food and Drug Administration (FDA).

While the drugs remain on the shortage list for now, they are no longer listed as "currently in shortage" by the FDA. Both Ozempic and Wegovy are forms of semaglutide, a GLP-1 agonist drug manufactured by Novo Nordisk.

When reached for comment, an FDA spokesperson told The Hill, "The FDA is currently working to determine whether the demand or........

© The Hill